129 related articles for article (PubMed ID: 21220230)
21. American Society of Clinical Oncology: Policy for relationships with companies.
American Society of Clinical Oncology
J Clin Oncol; 2013 Jun; 31(16):2043-6. PubMed ID: 23610118
[No Abstract] [Full Text] [Related]
22. The current management of malignancy -- VI other solid tumors.
Panettiere FJ
Alaska Med; 1977 Mar; 19(2):19-25. PubMed ID: 326087
[No Abstract] [Full Text] [Related]
23. [2015 through the eyes of the Bulletin of Cancer editorial board].
Magné N; Massard C; Bay JO; André T; Blay JY; Goncalves A; Orbach D; Wislez M; Thariat J; Penel N; Rancoule C; Vignot S
Bull Cancer; 2016 Jan; 103(1):3-17. PubMed ID: 26782079
[TBL] [Abstract][Full Text] [Related]
24. How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599.
Dornbusch D; Allegra C; Willey J; Andrews M; Leff R; Epstein J; Jones J; Lokey L; Green MR
Oncologist; 2006 Jan; 11(1):31-8. PubMed ID: 16401711
[TBL] [Abstract][Full Text] [Related]
25. [A clinico-experimental study in metronomic therapy of disseminated solid tumors].
Chudenko VA; Moiseenko VM
Vopr Onkol; 2009; 55(3):327-34. PubMed ID: 19670733
[TBL] [Abstract][Full Text] [Related]
26. American Society of Echocardiography minimum standards for the cardiac sonographer: a position paper.
Bierig SM; Ehler D; Knoll ML; Waggoner AD;
J Am Soc Echocardiogr; 2006 May; 19(5):471-4. PubMed ID: 16644428
[No Abstract] [Full Text] [Related]
27. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Brus C; Saif MW
JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer.
Djalalov S; Beca J; Hoch JS; Krahn M; Tsao MS; Cutz JC; Leighl NB
J Clin Oncol; 2014 Apr; 32(10):1012-9. PubMed ID: 24567430
[TBL] [Abstract][Full Text] [Related]
29. Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic options.
Lazzari C; Spitaleri G; Catania C; Barberis M; Noberasco C; Santarpia M; Delmonte A; Toffalorio F; Conforti F; De Pas TM
Crit Rev Oncol Hematol; 2014 Mar; 89(3):358-65. PubMed ID: 24156959
[TBL] [Abstract][Full Text] [Related]
30. Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumors.
Bauer S; Hartmann JT
Crit Rev Oncol Hematol; 2006 Nov; 60(2):112-30. PubMed ID: 16949832
[TBL] [Abstract][Full Text] [Related]
31. Practice parameters may benefit employers.
Malamud P
Bus Health; 1992 Jun; 10(7):34-6, 38, 42-3. PubMed ID: 10119130
[No Abstract] [Full Text] [Related]
32. Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.
Donato BM; Burns L; Willey V; Cohenuram M; Oliveria S; Yood MU
Clin Ther; 2010 Mar; 32(3):546-54. PubMed ID: 20399992
[TBL] [Abstract][Full Text] [Related]
33. [Gene therapy approaches to gastrointestinal tumors].
Löhr M
Z Gastroenterol; 2006 Apr; 44(4):333-40. PubMed ID: 16625463
[TBL] [Abstract][Full Text] [Related]
34. First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Merl MY; Abdelghany O; Li J; Saif MW
JOP; 2010 Jul; 11(4):317-20. PubMed ID: 20601801
[TBL] [Abstract][Full Text] [Related]
35. Practice parameters: a foundation for quality advancement.
Kelly JT; Swartwout JE
AAPPO J; 1991; 1(1):33-8. PubMed ID: 10148894
[No Abstract] [Full Text] [Related]
36. [2019 international oncology news: A compendium].
Magné N; Sabatier R; Wislez M; André T; Rodrigues M; Hervé L; Thiery-Vuillemin A; Penel N; Bouleuc C; Bay JO
Bull Cancer; 2020 Feb; 107(2):148-156. PubMed ID: 32057466
[TBL] [Abstract][Full Text] [Related]
37. The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members.
; Ganz PA; Kwan L; Somerfield MR; Alberts D; Garber JE; Offit K; Lippman SM
J Clin Oncol; 2006 Jun; 24(18):2948-57. PubMed ID: 16702579
[TBL] [Abstract][Full Text] [Related]
38. Negative data from lung cancer trial may change practice guidelines, study designs.
McNeil C
J Natl Cancer Inst; 2006 Nov; 98(21):1518-20. PubMed ID: 17077353
[No Abstract] [Full Text] [Related]
39. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW
J Clin Oncol; 2015 Mar; 33(8):952-63. PubMed ID: 25572671
[TBL] [Abstract][Full Text] [Related]
40. Statement on the care of the child with chronic lung disease of infancy and childhood.
Allen J; Zwerdling R; Ehrenkranz R; Gaultier C; Geggel R; Greenough A; Kleinman R; Klijanowicz A; Martinez F; Ozdemir A; Panitch HB; Nickerson B; Stein MT; Tomezsko J; Van Der Anker J;
Am J Respir Crit Care Med; 2003 Aug; 168(3):356-96. PubMed ID: 12888611
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
